| Model Number |
3400 |
| Medical Device Problem Codes |
Over-Sensing (1438); Inappropriate/Inadequate Shock/Stimulation (1574); Failure to Read Input Signal (1581)
|
| Health Effect - Clinical Code |
Shock from Patient Lead(s) (3162)
|
| Date of Event |
12/26/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) system delivered an inappropriate electric shock due to oversensing.It was also noted that the smart pass feature was disabled prior this shock per health care professional (hcp).Technical services (ts) reviewed and noted af/flutter episodes during sleep, qrs changes from 2mv to 1.2mv with wider complexes, and patient now in flutter/fib.Smart pass was re-enabled, stable r-wave observed in sleeping position.Plan is cardioversion next week, if amplitude returns to 2mv.At this time this product remains in service and no adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
This product remains in service and has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.With the available information, boston scientific concluded the clinical observation of oversensing is a known inherent risk of the product and is noted within the instructions for use (ifu), as well as the product's risk documentation.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.This device remains in service.As such, physical analysis has not been conducted in our laboratory.However, a labeling review and risk review were conducted.These reviews determined that the clinical observation of oversensing is a known inherent risk of the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance with labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.This oversensing has been observed with this product previously and is a known inherent risk associated with its use and is documented in the labeling of this product.
|
| |
|
Event or Problem Description
|
|
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) system delivered an inappropriate electric shock due to oversensing.It was also noted that the smart pass feature was disabled prior this shock per health care professional (hcp).Technical services (ts) reviewed and noted af/flutter episodes during sleep, qrs changes from 2mv to 1.2mv with wider complexes, and patient now in flutter/fib.Smart pass was re-enabled, stable r-wave observed in sleeping position.Plan is cardioversion next week, if amplitude returns to 2mv.At this time this product remains in service and no adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|